Figure 1. Hospital Revenues and Estimated Profits From the Outpatient Administration of Medicare Part B–Covered, Physician-Administered Drugs Paid by Medicare and Medicare Beneficiaries by Total per Hospital and Restricted to Oncology Only, 2013-2016.

Per-hospital revenue and estimated profits are shown, and total revenue and estimated profits in millions of dollars are shown under the bars. Calculations are based on data constructed and described in eTable 1 in the Supplement. The sample includes nonprofit and public general acute care hospitals participating in the 340B program in each year. Revenue and estimated profits are defined as the amount hospitals receive for outpatient physician-administered drug treatment covered under Part B and paid by Medicare and Medicare beneficiaries.

^aThe figures presented are estimated based on an assumption that the cost of drugs under the 340B program are equal to 50% of revenue. Outpatient oncology drug administrations are drug administrations for oncology J-codes as identified by a previously published report.²¹